In this talk, Hatim Abdulhussein explores how strategic public-pharma collaborations are harnessing artificial intelligence to reshape the future of healthcare. Drawing on recent work with Roche Diagnostics and Beigene, he will highlight how machine learning is being used to design predictive care pathways that integrate diagnostic insights with clinical decision-making as well as engaging communities. The session will also showcase a partnership with Pfizer focused on personalising electronic patient information—ensuring that individuals receive tailored, accessible, and actionable data to support their treatment journeys. Through these examples, the talk will illustrate how AI can drive scalable innovation while remaining grounded in patient-centred values and public accountability.